In January 2013, the FDA proposed a new rule requiring manufacturers to demonstrate the safety of all-metal hip implants before they could continue to sell these medical devices. This proposal attempted to close a loophole that has allowed manufacturers to sell medical devices without first testing them; heretofore, manufacturers merely had to prove that a similar device was already on the market.
David Rudolph, an experienced IP litigator based in our San Francisco office, joined a panel of other distinguished IP lawyers in a roundtable discussion on Intellectual Property law published in the August 2013 issue of California Lawyer. [Read more…]
In its annual survey of attorneys who have obtained a high degree of peer recognition and professional achievement, Super Lawyers, a Thomson Reuters publication, has selected 20 Lieff Cabraser attorneys as 2013 Super Lawyers or Rising Stars. [Read more…]
In its annual listing of the largest verdicts, the National Law Journal ranked the $261 million verdict against Toshiba Corporation in a class action trial brought by direct purchases of Thin Film Transistor-Liquid Crystal Displays (“TFT-LCDs”) as the eight largest verdict in the U.S. in 2012. TFT-LCDs are used in flat-panel televisions as well as computer monitors, laptop computers, mobile phones, personal digital assistants, and other devices. [Read more…]
California Lawyer magazine has selected Richard M. Heimann as a recipient of its 17th annual California Lawyer Attorneys of the Year (CLAY) Award. The prestigious award is given to lawyers whose work had a significant impact in the preceding year. Mr. Heimann was recognized for his outstanding success in In re TFT-LCD (Flat Panel) Antitrust Litigation, MDL No. 1827 (N.D. Cal.), one of the nation’s most significant private cartel actions in the past 15 years. [Read more…]
Law360 reports that the European Medicines Agency (EMA) announced on Monday that it will meet in February 2013 to review the adverse side effects associated with third- and fourth-generation hormonal birth control pills such as Yaz. The EMA’s Pharmacovigilance Risk Assessment Committee will investigate whether to restrict later generation hormonal birth control pills, such as Yaz, to patients who are not able to take other contraceptives. [Read more…]
Over $750 million to date has been paid out to women who developed blood clots and other serious side effects from Yaz, Yasmin, Gianvi, and Ocella birth control pills. All of these medications are manufactured by Bayer. To date, Bayer has settled 3,500 of these birth control drug injury lawsuits. [Read more…]
Lieff Cabraser attorneys Michael Sobol, David Stellings, and Roger Heller have been named finalists for the 2012 Trial Lawyer of the Year Award presented by Public Justice for their outstanding accomplishments in the bank overdraft fee litigation, along with other members of the Plaintiffs’ Executive Committee in the litigation. The award is given to lawyers who win extraordinary verdicts, awards, or settlements for clients in cases with wide-ranging impact. [Read more…]
In its annual survey of attorneys who have obtained a high degree of peer recognition and professional achievement, Super Lawyers, a Thomson Reuters publication, has selected eight Lieff Cabraser attorneys from our San Francisco office as 2012 Northern California Super Lawyers and another seven Lieff Cabraser attorneys as 2012 Northern California Rising Stars.
Earlier this week, U.S. District Court Judge James Lawrence King has granted final approval to a $410 million settlement in the multi-district litigation against Bank of America for collecting excessive overdraft fees. The complaint charged that Bank of America processed debit card transactions in order of highest to lowest dollar amount to maximize the number of overdraft fees assessed to its customers. [Read more…]
The Columbia Law School magazine profiled class of 1961 alumni Robert Lieff, reviewing both his life’s work and his extensive philanthropy. “Lieff has shown an uncanny capacity to spur impact on a game-changing level.” [Read more…]
The global economic crisis has triggered a cascade of financial fraud litigation, affecting investors across different countries and legal jurisdictions. [Read more…]